These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 9792821)
1. Differential expression and mutation of the ras family genes in human breast cancer. Miyakis S; Sourvinos G; Spandidos DA Biochem Biophys Res Commun; 1998 Oct; 251(2):609-12. PubMed ID: 9792821 [TBL] [Abstract][Full Text] [Related]
2. Activation of RAS family genes in urothelial carcinoma. Boulalas I; Zaravinos A; Karyotis I; Delakas D; Spandidos DA J Urol; 2009 May; 181(5):2312-9. PubMed ID: 19303097 [TBL] [Abstract][Full Text] [Related]
3. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients. Conzelmann M; Linnemann U; Berger MR Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598 [TBL] [Abstract][Full Text] [Related]
4. Mutations and differential expression of the ras family genes in human nasal polyposis. Zaravinos A; Bizakis J; Soufla G; Sourvinos G; Spandidos DA Int J Oncol; 2007 Nov; 31(5):1051-9. PubMed ID: 17912430 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis. Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894 [TBL] [Abstract][Full Text] [Related]
6. Relationship between K-ras mutation and the expression of p21WAF1/CIP1 and p53 in chronic pancreatitis and pancreatic adenocarcinoma. Hermanová M; Lukás Z; Kroupová I; Kleibl Z; Novotný J; Nenutil R; Pazourková M; Brázdil J; Kren L; Díte P Neoplasma; 2003; 50(5):319-25. PubMed ID: 14628083 [TBL] [Abstract][Full Text] [Related]
7. Mutations and expression of the ras family genes in leukemias. Gougopoulou DM; Kiaris H; Ergazaki M; Anagnostopoulos NI; Grigoraki V; Spandidos DA Stem Cells; 1996 Nov; 14(6):725-9. PubMed ID: 8948029 [TBL] [Abstract][Full Text] [Related]
8. Suppression of ING1 expression in sporadic breast cancer. Toyama T; Iwase H; Watson P; Muzik H; Saettler E; Magliocco A; DiFrancesco L; Forsyth P; Garkavtsev I; Kobayashi S; Riabowol K Oncogene; 1999 Sep; 18(37):5187-93. PubMed ID: 10498868 [TBL] [Abstract][Full Text] [Related]
9. Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors. Jamieson S; Alexiadis M; Fuller PJ Gynecol Oncol; 2004 Dec; 95(3):603-9. PubMed ID: 15581971 [TBL] [Abstract][Full Text] [Related]
10. P53 and K-ras mutations are frequent events in microscopically negative surgical margins from patients with nonsmall cell lung carcinoma. Jassem J; Jassem E; Jakóbkiewicz-Banecka J; Rzyman W; Badzio A; Dziadziuszko R; Kobierska-Gulida G; Szymanowska A; Skrzypski M; Zylicz M Cancer; 2004 May; 100(9):1951-60. PubMed ID: 15112277 [TBL] [Abstract][Full Text] [Related]
11. Identification of genes showing differential expression in antisense K-ras-transduced pancreatic cancer cells with suppressed tumorigenicity. Ohnami S; Matsumoto N; Nakano M; Aoki K; Nagasaki K; Sugimura T; Terada M; Yoshida T Cancer Res; 1999 Nov; 59(21):5565-71. PubMed ID: 10554036 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer. Van den Eynden GG; Van Laere SJ; Van der Auwera I; Merajver SD; Van Marck EA; van Dam P; Vermeulen PB; Dirix LY; van Golen KL Breast Cancer Res Treat; 2006 Feb; 95(3):219-28. PubMed ID: 16244790 [TBL] [Abstract][Full Text] [Related]
13. Correlation of K-ras codon 12 mutations in human feces and ages of patients with colorectal cancer (CRC). Chien CC; Chen SH; Liu CC; Lee CL; Yang RN; Yang SH; Huang CJ Transl Res; 2007 Feb; 149(2):96-102. PubMed ID: 17240321 [TBL] [Abstract][Full Text] [Related]
14. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung. Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992 [TBL] [Abstract][Full Text] [Related]
15. Low mutational rate of K-ras codon 12 in singular bronchoscopy specimens in suspected lung cancer. Spasova I; Novotna H; Vachtenheim J; Bartosova H; Patek J; Hoserova V; Zatloukal P; Kinkor Z Neoplasma; 2005; 52(3):255-9. PubMed ID: 15875089 [TBL] [Abstract][Full Text] [Related]
16. The balanced induction of K-ras codon 12 and 13 mutations in mucosa differs from their ratio in neoplastic tissues. Kraus MC; Seelig MH; Linnemann U; Berger MR Int J Oncol; 2006 Oct; 29(4):957-64. PubMed ID: 16964391 [TBL] [Abstract][Full Text] [Related]
17. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray]. Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993 [TBL] [Abstract][Full Text] [Related]
18. Increase of GKLF messenger RNA and protein expression during progression of breast cancer. Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818 [TBL] [Abstract][Full Text] [Related]
19. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Al Sarakbi W; Mokbel R; Salhab M; Jiang WG; Reed MJ; Mokbel K Anticancer Res; 2006; 26(6C):4985-90. PubMed ID: 17214375 [TBL] [Abstract][Full Text] [Related]
20. Incidence of activating ras oncogene mutations associated with primary and metastatic human breast cancer. Rochlitz CF; Scott GK; Dodson JM; Liu E; Dollbaum C; Smith HS; Benz CC Cancer Res; 1989 Jan; 49(2):357-60. PubMed ID: 2642738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]